Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
Net earnings		$ 1,987	$ 1,464
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization		241	240
Deferred income tax (benefit) provision		(24)	(94)
Asset impairment and exit costs, net of cash paid (Note 18)		(48)	17
Cash effects of changes in:
Receivables, net		116	4
Inventories		(575)	237
Accounts payable		(65)	(7)
Accrued liabilities and other current assets		(662)	(855)
Income taxes		(54)	(251)
Pension plan contributions		(23)	(17)
Other		218	503	[1]
Net cash provided by operating activities		1,111	1,241
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES
Capital expenditures		(170)	(324)
Investments in unconsolidated subsidiaries and equity securities		(2)	(24)
Deconsolidation of RBH (Note 19)		0	(1,346)	[2]
Net investment hedges		684	91
Other		2	7
Net cash provided by (used in) investing activities		514	(1,596)
Short-term borrowing activity by original maturity:
Net issuances (repayments) - maturities of 90 days or less		1,097	(167)
Issuances - maturities longer than 90 days		25	989
Long-term debt repaid		(3,641)	(2,137)
Dividends paid		(1,828)	(1,780)
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests		2	0
Other		(204)	(56)
Net cash used in financing activities		(4,549)	(3,151)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(191)	(28)
Cash, cash equivalents and restricted cash:
Increase (Decrease)	[3]	(3,115)	(3,534)
Balance at beginning of period	[3]	6,865	6,620
Balance at end of period	[3]	$ 3,750	$ 3,086

[1] Includes the Loss on Deconsolidation of RBH ($239 million) and the Canadian tobacco litigation-related charge ($194 million) that were included in marketing, administration and research costs in the condensed consolidated statements of earnings for the three months ended March 31, 2019. For further details on these charges, see Note 19. Deconsolidation of RBH.

[2] Includes deconsolidation of RBH cash and cash equivalents of $1,323 million and restricted cash of $23 million.

[3] The amounts for cash and cash equivalents shown above include restricted cash of $4 million and $5 million as of March 31, 2020 and 2019, respectively, and $4 million and $27 million as of December 31, 2019, and 2018, respectively, which were included in other current assets in the condensed consolidated balance sheets.